Literature DB >> 6776559

Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus.

J C Winter.   

Abstract

Six rats were trained to discriminate the effects of LSD (100 micrograms/kg) and saline in a two-lever choice task. They were then tested with each of three phenethylamine derivatives, BL-3912 (2,5-dimethoxy-4-methyl-alpha-ethyl-phenethylamine), fenfluramine (N-ethyl-alpha-methyl-m-(trifluoro-methyl)phenethylamine), and Sch-12679 (N-methyl-1-phenyl-7,8-dimethoxy-2,3,4,5-tetra-hydro-3-benzazepine maleate). Fenfluramine and Sch-12679 yielded intermediate results, i.e., responding was not fully appropriate for either training condition while BL-3912 substituted completely for LSD. The LSD-like effects of each of the drugs were antagonized by pretreatment with BC-105, a serotonergic antagonist known to block the stimulus effects of indole and phenethylamine hallucinogens. The present data together with consideration of the known clinical effects of BL-3912, fenfluramine, and Sch-12679 are consistent with the following conclusions: (1) a variety of drugs may substitute in whole or in part for LSD in LSD-trained rats, and (2) even complete substitution of a drug for LSD in the rat is not necessarily associated with the production by that drug of hallucinations in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776559     DOI: 10.1007/bf00432134

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Differences in the stimulus properties of barbital and hallucinogens.

Authors:  I D Hirschhorn; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  1975 May-Jun       Impact factor: 3.533

2.  The non-medical misuse of fenfluramine by drug-dependent young South Africans.

Authors:  A Levin
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

3.  A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).

Authors:  I D Hirschhorn; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1974-05       Impact factor: 3.533

4.  A comparative study of the pharmacologic actions of amphetamine and fenfluramine.

Authors:  J Yelnosky; R B Lawlor
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-04

5.  Blockade of the stimulus properties of mescaline by a serotonin antagonist.

Authors:  J C Winter
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-04

6.  A clinical trial of a benzazepine (SCH 12679) in acute schizophrenic patients.

Authors:  S Park; S Gershon; A Floyd
Journal:  Curr Ther Res Clin Exp       Date:  1972-06

7.  Clinical, toxicological and electroencephalographic study with SCH-12,679 in chronic schizophrenics.

Authors:  A Keskiner; T M Itil; T H Han; B Saletu; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1971-11

8.  The identification of LSD-like hallucinogens using the chronic spinal dog.

Authors:  W R Martin; D B Vaupel; M Nozaki; L D Bright
Journal:  Drug Alcohol Depend       Date:  1978-03       Impact factor: 4.492

9.  Further studies on BL-3912A: effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock.

Authors:  H A Tilson; J H Chamberlain; J A Gylys
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

10.  DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug. Effects of varying doses in man.

Authors:  S H Snyder; H Weingartner; L A Faillace
Journal:  Arch Gen Psychiatry       Date:  1971-01
View more
  7 in total

1.  Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Authors:  J Koerner; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.

Authors:  F J White; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Authors:  P A Pierce; S J Peroutka
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  Clinical features and management of intoxication due to hallucinogenic drugs.

Authors:  J B Leikin; A J Krantz; M Zell-Kanter; R L Barkin; D O Hryhorczuk
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

6.  Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; Jason Wallach; Simon D Brandt
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.273

Review 7.  Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.

Authors:  David E Nichols
Journal:  Front Psychiatry       Date:  2022-03-25       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.